Literature DB >> 20557770

Vasospasm and delayed consequences.

S Bracard1, E Schmitt.   

Abstract

Entities:  

Year:  2008        PMID： 20557770      PMCID： PMC3328054          DOI： 10.1177/15910199080140S105

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


× No keyword cloud information.
  45 in total

Review 1.  Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm.

Authors:  J M Mathis; M E Jensen; J E Dion
Journal:  Neuroradiology       Date:  1997-02       Impact factor: 2.804

2.  Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging.

Authors:  M Shimoda; M Takeuchi; J Tominaga; S Oda; A Kumasaka; R Tsugane
Journal:  Neurosurgery       Date:  2001-12       Impact factor: 4.654

3.  Health-related quality of life after aneurysmal subarachnoid hemorrhage: impacts of bleeding severity, computerized tomography findings, surgery, vasospasm, and neurological grade.

Authors:  B O Hütter; I Kreitschmann-Andermahr; J M Gilsbach
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

4.  Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  H Ohkuma; H Manabe; M Tanaka; S Suzuki
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

5.  Relevance of diffusion and perfusion weighted mri for endovascular treatment of vasospasm in subarachnoid hemorrhage.

Authors:  S Bracard; R Anxionnat; S Auliac; J Melo Neto; A Lebendinsky; G Audibert; L Picard
Journal:  J Neuroradiol       Date:  2001-03       Impact factor: 3.447

Review 6.  Advances in vasospasm treatment and prevention.

Authors:  Ricardo J Komotar; Brad E Zacharia; Ricky Valhora; J Mocco; E Sander Connolly
Journal:  J Neurol Sci       Date:  2007-06-13       Impact factor: 3.181

7.  Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography.

Authors:  X Leclerc; A Fichten; J Y Gauvrit; B Riegel; M Steinling; J P Lejeune; J P Pruvo
Journal:  Neuroradiology       Date:  2002-05-28       Impact factor: 2.804

8.  Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial.

Authors:  Marike Zwienenberg-Lee; Jonathan Hartman; Nancy Rudisill; Lori Kennedy Madden; Karen Smith; Joseph Eskridge; David Newell; Bon Verweij; M Ross Bullock; Andrew Baker; William Coplin; Robert Mericle; Jian Dai; David Rocke; J Paul Muizelaar
Journal:  Stroke       Date:  2008-04-17       Impact factor: 7.914

9.  Arterial wall changes in early human vasospasm.

Authors:  R R Smith; B R Clower; G M Grotendorst; N Yabuno; J M Cruse
Journal:  Neurosurgery       Date:  1985-02       Impact factor: 4.654

10.  Organic psychiatric disorders after aneurysmal SAH: outcome and associations with age, bleeding severity, and arterial hypertension.

Authors:  M Rödholm; J-E Starmark; S Ekholm; C von Essen
Journal:  Acta Neurol Scand       Date:  2002-07       Impact factor: 3.209
View more
  2 in total

Review 1.  Carbon monoxide attenuates vasospasm and improves neurobehavioral function after subarachnoid hemorrhage.

Authors:  Pradip K Kamat; Abdullah S Ahmad; Sylvain Doré
Journal:  Arch Biochem Biophys       Date:  2019-09-24       Impact factor: 4.013

2.  Treatment during cerebral vasospasm phase-complication association and outcome in aneurysmal subarachnoid haemorrhage.

Authors:  Isabel C Hostettler; Kornelia Kreiser; Maria Wostrack; Bernhard Meyer; Nicole Lange; Nina Schwendinger; Dominik Trost; Samira Frangoulis; Theresa Hirle; Jens Gempt
Journal:  J Neurol       Date:  2022-06-22       Impact factor: 6.682
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.